References
- Lysy J, Werczberger A, Globus M, Chowers I. Pneumatocele formation in a patient with Proteus mirabilis pneumonia. Postgrad Med J 1985;61:255-7. https://doi.org/10.1136/pgmj.61.713.255
- McGarry T, Giosa R, Rohman M, Huang CT. Pneumatocele formation in adult pneumonia. Chest 1987;92:717-20. https://doi.org/10.1378/chest.92.4.717
- Meyers HI, Jacobson G. Staphylococcal pneumonia in children and adults. Radiology 1959;72:665-71. https://doi.org/10.1148/72.5.665
- Ceruti E, Contreras J, Neira M. Staphylococcal pneumonia in childhood: long-term follow-up including pulmonary function studies. Am J Dis Child 1971;122:386-92. https://doi.org/10.1001/archpedi.1971.02110050056004
- Thapa BR, Kumar L, Mitra SK. Proteus mirabilis pneumonia with giant pneumatocele. Indian J Pediatr 1987;54:593-7. https://doi.org/10.1007/BF02749061
- Wu JJ, Chen HM, Ko WC, Wu HM, Tsai SH, Yan JJ. Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66). Diagn Microbiol Infect Dis 2008;60:169-75. https://doi.org/10.1016/j.diagmicrobio.2007.08.004
- Endimiani A, Luzzaro F, Brigante G, Perilli M, Lombardi G, Amicosante G, et al. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005;49:2598-605. https://doi.org/10.1128/AAC.49.7.2598-2605.2005
- O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella . Clin Microbiol Rev 2000;13:534-46. https://doi.org/10.1128/CMR.13.4.534-546.2000
- Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003;47:273-95. https://doi.org/10.1016/S0163-4453(03)00096-3
- de Champs C, Bonnet R, Sirot D, Chanal C, Sirot J. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J Antimicrob Chemother 2000;45:537-9. https://doi.org/10.1093/jac/45.4.537
- Okimoto N, Hayashi T, Ishiga M, Nanba F, Kishimoto M, Yagi S, et al. Clinical features of Proteus mirabilis pneumonia. J Infect Chemother 2010;16:364-6. https://doi.org/10.1007/s10156-010-0059-3
- Kim JY, Park YJ, Kim SI, Kang MW, Lee SO, Lee KY. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. J Antimicrob Chemother 2004;54:1144-7. https://doi.org/10.1093/jac/dkh486
- Quigley MJ, Fraser RS. Pulmonary pneumatocele: pathology and pathogenesis. AJR Am J Roentgenol 1988;150:1275-7. https://doi.org/10.2214/ajr.150.6.1275
- Zuhdi MK, Spear RM, Worthen HM, Peterson BM. Percutaneous catheter drainage of tension pneumatocele, secondarily infected pneumatocele, and lung abscess in children. Crit Care Med 1996;24:330-3. https://doi.org/10.1097/00003246-199602000-00024
Cited by
- Pneumatocele formation in a fatal adult pneumonia patient coinfected with Streptococcus pyogenes emm -type 3 and influenza A: a case report vol.20, pp.1, 2015, https://doi.org/10.1186/s12879-020-05595-2